カテゴリ： 世界, 医療/バイオ, Market Monitor Global

ゲパンツドラッグのグローバル市場展望 2023年-2029年：リメゲパン、アトゲパン、ザベゲパン、ウブロゲパン

■ 英語タイトル：Gepants Drugs Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14341）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14341
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：83
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ゲパンツドラッグのグローバル市場展望 2023年-2029年：リメゲパン、アトゲパン、ザベゲパン、ウブロゲパン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のゲパンツドラッグ市場規模と予測を収録しています。・世界のゲパンツドラッグ市場：売上、2018年-2023年、2024年-2029年
・世界のゲパンツドラッグ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のゲパンツドラッグ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リメゲパン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ゲパンツドラッグのグローバル主要企業は、PFIZER INC、 ABBVIE INCなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ゲパンツドラッグのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のゲパンツドラッグ市場：タイプ別、2018年-2023年、2024年-2029年
世界のゲパンツドラッグ市場：タイプ別市場シェア、2022年
・リメゲパン、アトゲパン、ザベゲパン、ウブロゲパン

世界のゲパンツドラッグ市場：用途別、2018年-2023年、2024年-2029年
世界のゲパンツドラッグ市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のゲパンツドラッグ市場：地域・国別、2018年-2023年、2024年-2029年
世界のゲパンツドラッグ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるゲパンツドラッグのグローバル売上、2018年-2023年
・主要企業におけるゲパンツドラッグのグローバル売上シェア、2022年
・主要企業におけるゲパンツドラッグのグローバル販売量、2018年-2023年
・主要企業におけるゲパンツドラッグのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
PFIZER INC、 ABBVIE INC

*************************************************************

・調査・分析レポートの概要
ゲパンツドラッグ市場の定義
市場セグメント
世界のゲパンツドラッグ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のゲパンツドラッグ市場規模
世界のゲパンツドラッグ市場規模：2022年 VS 2029年
世界のゲパンツドラッグ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのゲパンツドラッグの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のゲパンツドラッグ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：リメゲパン、アトゲパン、ザベゲパン、ウブロゲパン
ゲパンツドラッグのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
ゲパンツドラッグの用途別グローバル売上・予測

・地域別市場分析
地域別ゲパンツドラッグ市場規模 2022年と2029年
地域別ゲパンツドラッグ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
PFIZER INC、 ABBVIE INC
...

This research report provides a comprehensive analysis of the Gepants Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Gepants Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Gepants Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Gepants Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Gepants Drugs market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Gepants Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Gepants Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Gepants Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Gepants Drugs market.
Market Overview: The report provides a comprehensive overview of the Gepants Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Rimegepant, Atogepant), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Gepants Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Gepants Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Gepants Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Gepants Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Gepants Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Gepants Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Gepants Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Gepants Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Gepants Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Rimegepant
Atogepant
Zavegepant
Ubrogepant
Market segment by Application
Hospital
Clinic
Other
Global Gepants Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
PFIZER INC
ABBVIE INC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gepants Drugs, market overview.
Chapter 2: Global Gepants Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gepants Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gepants Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gepants Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Gepants Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gepants Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gepants Drugs Overall Market Size
2.1 Global Gepants Drugs Market Size: 2022 VS 2029
2.2 Global Gepants Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gepants Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gepants Drugs Players in Global Market
3.2 Top Global Gepants Drugs Companies Ranked by Revenue
3.3 Global Gepants Drugs Revenue by Companies
3.4 Global Gepants Drugs Sales by Companies
3.5 Global Gepants Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gepants Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gepants Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gepants Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gepants Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gepants Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gepants Drugs Market Size Markets, 2022 & 2029
4.1.2 Rimegepant
4.1.3 Atogepant
4.1.4 Zavegepant
4.1.5 Ubrogepant
4.2 By Type – Global Gepants Drugs Revenue & Forecasts
4.2.1 By Type – Global Gepants Drugs Revenue, 2018-2023
4.2.2 By Type – Global Gepants Drugs Revenue, 2024-2029
4.2.3 By Type – Global Gepants Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Gepants Drugs Sales & Forecasts
4.3.1 By Type – Global Gepants Drugs Sales, 2018-2023
4.3.2 By Type – Global Gepants Drugs Sales, 2024-2029
4.3.3 By Type – Global Gepants Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Gepants Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gepants Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Gepants Drugs Revenue & Forecasts
5.2.1 By Application – Global Gepants Drugs Revenue, 2018-2023
5.2.2 By Application – Global Gepants Drugs Revenue, 2024-2029
5.2.3 By Application – Global Gepants Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Gepants Drugs Sales & Forecasts
5.3.1 By Application – Global Gepants Drugs Sales, 2018-2023
5.3.2 By Application – Global Gepants Drugs Sales, 2024-2029
5.3.3 By Application – Global Gepants Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Gepants Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gepants Drugs Market Size, 2022 & 2029
6.2 By Region – Global Gepants Drugs Revenue & Forecasts
6.2.1 By Region – Global Gepants Drugs Revenue, 2018-2023
6.2.2 By Region – Global Gepants Drugs Revenue, 2024-2029
6.2.3 By Region – Global Gepants Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Gepants Drugs Sales & Forecasts
6.3.1 By Region – Global Gepants Drugs Sales, 2018-2023
6.3.2 By Region – Global Gepants Drugs Sales, 2024-2029
6.3.3 By Region – Global Gepants Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gepants Drugs Revenue, 2018-2029
6.4.2 By Country – North America Gepants Drugs Sales, 2018-2029
6.4.3 US Gepants Drugs Market Size, 2018-2029
6.4.4 Canada Gepants Drugs Market Size, 2018-2029
6.4.5 Mexico Gepants Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gepants Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Gepants Drugs Sales, 2018-2029
6.5.3 Germany Gepants Drugs Market Size, 2018-2029
6.5.4 France Gepants Drugs Market Size, 2018-2029
6.5.5 U.K. Gepants Drugs Market Size, 2018-2029
6.5.6 Italy Gepants Drugs Market Size, 2018-2029
6.5.7 Russia Gepants Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gepants Drugs Market Size, 2018-2029
6.5.9 Benelux Gepants Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gepants Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Gepants Drugs Sales, 2018-2029
6.6.3 China Gepants Drugs Market Size, 2018-2029
6.6.4 Japan Gepants Drugs Market Size, 2018-2029
6.6.5 South Korea Gepants Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gepants Drugs Market Size, 2018-2029
6.6.7 India Gepants Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gepants Drugs Revenue, 2018-2029
6.7.2 By Country – South America Gepants Drugs Sales, 2018-2029
6.7.3 Brazil Gepants Drugs Market Size, 2018-2029
6.7.4 Argentina Gepants Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gepants Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gepants Drugs Sales, 2018-2029
6.8.3 Turkey Gepants Drugs Market Size, 2018-2029
6.8.4 Israel Gepants Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gepants Drugs Market Size, 2018-2029
6.8.6 UAE Gepants Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 PFIZER INC
7.1.1 PFIZER INC Company Summary
7.1.2 PFIZER INC Business Overview
7.1.3 PFIZER INC Gepants Drugs Major Product Offerings
7.1.4 PFIZER INC Gepants Drugs Sales and Revenue in Global (2018-2023)
7.1.5 PFIZER INC Key News & Latest Developments
7.2 ABBVIE INC
7.2.1 ABBVIE INC Company Summary
7.2.2 ABBVIE INC Business Overview
7.2.3 ABBVIE INC Gepants Drugs Major Product Offerings
7.2.4 ABBVIE INC Gepants Drugs Sales and Revenue in Global (2018-2023)
7.2.5 ABBVIE INC Key News & Latest Developments
8 Global Gepants Drugs Production Capacity, Analysis
8.1 Global Gepants Drugs Production Capacity, 2018-2029
8.2 Gepants Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gepants Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gepants Drugs Supply Chain Analysis
10.1 Gepants Drugs Industry Value Chain
10.2 Gepants Drugs Upstream Market
10.3 Gepants Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gepants Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Gepants Drugs in Global Market
Table 2. Top Gepants Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gepants Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gepants Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gepants Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Gepants Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gepants Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gepants Drugs Product Type
Table 9. List of Global Tier 1 Gepants Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gepants Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Gepants Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gepants Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gepants Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gepants Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Gepants Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Gepants Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gepants Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gepants Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gepants Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Gepants Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Gepants Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gepants Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gepants Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gepants Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Gepants Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Gepants Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gepants Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gepants Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Gepants Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Gepants Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gepants Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gepants Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gepants Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Gepants Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gepants Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gepants Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gepants Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Gepants Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gepants Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gepants Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Gepants Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Gepants Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gepants Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gepants Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gepants Drugs Sales, (K Units), 2024-2029
Table 46. PFIZER INC Company Summary
Table 47. PFIZER INC Gepants Drugs Product Offerings
Table 48. PFIZER INC Gepants Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. PFIZER INC Key News & Latest Developments
Table 50. ABBVIE INC Company Summary
Table 51. ABBVIE INC Gepants Drugs Product Offerings
Table 52. ABBVIE INC Gepants Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. ABBVIE INC Key News & Latest Developments
Table 54. Gepants Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Gepants Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Gepants Drugs Production by Region, 2018-2023 (K Units)
Table 57. Global Gepants Drugs Production by Region, 2024-2029 (K Units)
Table 58. Gepants Drugs Market Opportunities & Trends in Global Market
Table 59. Gepants Drugs Market Drivers in Global Market
Table 60. Gepants Drugs Market Restraints in Global Market
Table 61. Gepants Drugs Raw Materials
Table 62. Gepants Drugs Raw Materials Suppliers in Global Market
Table 63. Typical Gepants Drugs Downstream
Table 64. Gepants Drugs Downstream Clients in Global Market
Table 65. Gepants Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gepants Drugs Segment by Type in 2022
Figure 2. Gepants Drugs Segment by Application in 2022
Figure 3. Global Gepants Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gepants Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gepants Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Gepants Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gepants Drugs Revenue in 2022
Figure 9. By Type - Global Gepants Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gepants Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gepants Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Gepants Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Gepants Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gepants Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gepants Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Gepants Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Gepants Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gepants Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gepants Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gepants Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Gepants Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gepants Drugs Sales Market Share, 2018-2029
Figure 23. US Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gepants Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gepants Drugs Sales Market Share, 2018-2029
Figure 28. Germany Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gepants Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gepants Drugs Sales Market Share, 2018-2029
Figure 37. China Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gepants Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gepants Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gepants Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gepants Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gepants Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gepants Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Gepants Drugs by Region, 2022 VS 2029
Figure 54. Gepants Drugs Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • イボシデニブ薬のグローバル市場展望 2023年-2029年：60錠、30錠
  • ソマバート薬のグローバル市場展望 2023年-2029年：プレフィルド、ノンプレフィルド
  • ポナチニブ薬のグローバル市場展望 2023年-2029年：45mg、15mg
  • クロファラビン製剤のグローバル市場展望 2023年-2029年：エボルトラ、クロラール
  • ダサチニブ薬のグローバル市場展望 2023年-2029年：20mg、50mg、70mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14341 )"ゲパンツドラッグのグローバル市場展望 2023年-2029年：リメゲパン、アトゲパン、ザベゲパン、ウブロゲパン" (英文：Gepants Drugs Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。